These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32123659)
1. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Mtibaa L; Halwani C; Tbini M; Boufares S; Souid H; Ben Sassi R; Gharsallah H; Ben Mhamed R; Akkari K; Jemli B Med Mycol Case Rep; 2020 Mar; 27():64-67. PubMed ID: 32123659 [TBL] [Abstract][Full Text] [Related]
2. Successful therapy of progressive rhino-orbital mucormycosis caused by Rhizopus arrhizus with combined and sequential antifungal therapy, surgery and hyperbaric therapy. Imbernón A; Agud JL; Cuétara MS; Casqueiro JC; Nuñez P; Domínguez AR; Bullido E; Stchigel AM Med Mycol Case Rep; 2014 Oct; 6():51-4. PubMed ID: 25383316 [TBL] [Abstract][Full Text] [Related]
3. Outcome of mucormycosis after treatment: report of five cases. Bellazreg F; Hattab Z; Meksi S; Mansouri S; Hachfi W; Kaabia N; Ben Said M; Letaief A New Microbes New Infect; 2015 Jul; 6():49-52. PubMed ID: 26137308 [TBL] [Abstract][Full Text] [Related]
4. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Bala K; Chander J; Handa U; Punia RS; Attri AK Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of Miller RP; Farrugia L; Leask J; Khalsa K; Khanna N; Melia L Med Mycol Case Rep; 2021 Jun; 32():39-42. PubMed ID: 33816097 [TBL] [Abstract][Full Text] [Related]
6. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases. Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454 [TBL] [Abstract][Full Text] [Related]
7. Rhino-Orbito-Cerebral Mucormycosis: A Challenging Case. El Hakkouni A; Harrar S; Hachimi A; Mezouari M; Moutaj R Cureus; 2023 Sep; 15(9):e44768. PubMed ID: 37809164 [TBL] [Abstract][Full Text] [Related]
8. [Rhino-orbito-cerebral mucormycosis from dental origin: Case report]. Bravo JH; Agudelo AM; Cortés A; Matta L Biomedica; 2018 Mar; 38(1):27-31. PubMed ID: 29668130 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma. Athanasiadou KI; Athanasiadis DI; Constantinidis J; Anastasiou A; Roilides E; Papakonstantinou E Med Mycol Case Rep; 2019 Sep; 25():10-14. PubMed ID: 31245270 [TBL] [Abstract][Full Text] [Related]
10. Mucormycosis with cutaneous involvement. A retrospective study of 115 cases at a tertiary care hospital in Mexico. Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Kassack JJ; Araiza J; González GM Australas J Dermatol; 2021 May; 62(2):162-167. PubMed ID: 33222179 [TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole. Cham CY; P Radhakrishnan A; Chang CY Cureus; 2023 Mar; 15(3):e35814. PubMed ID: 37033497 [TBL] [Abstract][Full Text] [Related]
12. [Adjunctive treatment with hyperbaric oxygen in a patient with rhino-sinuso-orbital mucormycosis]. Melero M; Kaimen Maciel I; Tiraboschi N; Botargues M; Radisic M Medicina (B Aires); 1991; 51(1):53-5. PubMed ID: 1921693 [TBL] [Abstract][Full Text] [Related]
14. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy. Almannai M; Imran H; Estrada B; Siddiqui AH Pediatr Hematol Oncol; 2013 Apr; 30(3):184-6. PubMed ID: 23444832 [TBL] [Abstract][Full Text] [Related]
16. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India. Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary mucormycosis in a diabetic patient. Vincent L; Biron F; Jardin P; Piens M; Dannaoui E; Isaac S; Guibert B; Pacheco Y Ann Med Interne (Paris); 2000 Dec; 151(8):669-72. PubMed ID: 11173713 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran. Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164 [TBL] [Abstract][Full Text] [Related]
19. Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Davies GE; Thornton CR J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887511 [TBL] [Abstract][Full Text] [Related]
20. Case Report: Li DM; Lun L; Ge J; Zhang GJ; Li XL; de Hoog GS Front Med (Lausanne); 2021; 8():578684. PubMed ID: 34150783 [No Abstract] [Full Text] [Related] [Next] [New Search]